FDA Issues &#39;Approvable Letter&#39; for Certican
547717
BASEL, Switzerland, August 30 /PRNewswire/ -- Novartis Pharma AG has received an &quot;approvable&quot; letter from the US Food and Drug Administration (FDA) for Certican (everolimus) in combination with Neoral (ciclosporin for microemulsion) for the prevention of
135195
We can&#39;t isolate ourselves from every danger. That was the message from the Food and Drug Administration. We can&#39;t isolate ourselves from the danger of the FDA.
66408
NEW YORK - On. Dec. 17, the US Food and Drug Administration released a statement relating to Pfizer&#39;s (nyse: PFE - news - people ) Celebrex.
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
276583
Swiss pharmaceutical maker Novartis AG said Tuesday it has received U.
502595
The Food and Drug Administration is responding to the widespread criticism of the government's handling of drug safety problems.
74243
Emeryville drug company Chiron Corp. said Friday it has gotten a warning letter from the US Food and Drug Administration about its flu vaccine manufacturing.
300123
The Food and Drug Administration announcement comes as a response to criticism that the government has reacted too slowly to the dangers posed by popular supplements.
119342
The Food and Drug Administration launched an effort this week to use radio frequency identification technology to track the nation&#39;s drug supply from manufacturer to pharmacy to reduce counterfeiting.
710983
Encysive receives another approvable letter for its lead drug.
691976
Washington, Dec 16 : One-fifth of the US Food and Drug Administration (FDA) scientists surveyed as part of an official review have said they had been pressured to recommend approval of a new drug despite their reservations about its safety, effectiveness
412808
The US Food and Drug Administration (FDA) has said that food companies will be allowed to make qualified health claims about the monounsaturated fat contained in olive oil.
702130
The Food and Drug Administration said yesterday that fish and other foods and dietary supplements containing omega-3 fatty acids can claim on their labels that they help reduce the risk of
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
425484
Wyeth  said on Monday that it received a second approvable letter from U.S regulators for bazedoxifene, a drug that helps prevent bone deterioration in post-menopausal women.
737440
An unsurprising response from the FDA.
212798
NEW YORK, December 16  - Specialty pharmaceutical company Sepracor (SEPR.NAS) announced yesterday that it had received the FDA approval for marketing its Lunesta treatment for insomnia.